Skip to main content
SpringerLink
Log in

Ramoplanin

A 16686, A 16686A, MDL 62198

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Notes

  1. This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.

References

  1. Biosearch Italia SpA. Biosearch Italia Reacquires Rights to Ramoplanin for Topical Use from IntraBiotics Media Release: 13 May 2002. Available from: URL http://www. biosearch.it

    Google Scholar 

  2. Patoia L, Berchicci P. Ramoplanin. Drugs of the Future 15: 689–694, Jul 1990

    Google Scholar 

  3. Romeo B, Kaschube M, Cavenaghi L, Borgonovi M, Jaulhac B, et al. Repeated doses of ramoplanin orally administered to healthy male volunteers: tolerability, lack of absorption and effect on the stool microflora. 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy: 200, 1993

    Google Scholar 

  4. Bertazzoni Minelli E, Benini A, Muner A, et al. Ramoplanin and human intestinal contents: in vitro interactions. 9th Mediterranean Congress of Chemotherapy p.90, 1994

    Google Scholar 

  5. Landman D, Quale JM, Burney S, Kreiswirth B, Willey BM. Treatment of experimental endocarditis caused by multidrug resistant Enterococcus faecium with ramoplanin and penicillin. Journal of Antimicrobial Chemotherapy 37: 323–329, Feb 1996

    Article  PubMed  CAS  Google Scholar 

  6. Lawrence T, Rotstein C, Beam Jr TR, Gorzynski EA, Amsterdam D. In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of Gram-positive cocci. Antimicrobial Agents and Chemotherapy 37: 896–900, Apr 1993

    Article  PubMed  CAS  Google Scholar 

  7. Collins LA, Eliopoulos GM, Wennersten CB, Ferraro MJ, Moellering Jr RC. In vitro activity of ramoplanin against vancomycin- resistant Gram-positive organisms. Antimicrobial Agents and Chemotherapy 37: 1364–1366, Jun 1993

    Article  PubMed  CAS  Google Scholar 

  8. Johnson CC, Taylor S, Pitsakis P, May P, Levison ME. Bactericidal activity of ramoplanin against antibiotic-resistant enterococci. Antimicrobial Agents and Chemotherapy 36: 2342–2345, Oct 1992

    Article  PubMed  CAS  Google Scholar 

  9. Mobarakai N, Quale JM, Landman D. Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy 38: 385–387, Feb 1994

    Article  PubMed  CAS  Google Scholar 

  10. Wong MT, Porter SB, Kauffman CA, Standiford HC, Fuchs HJ, et al. Clinical efficacy and safety phase II trial of the novel glycolipodepsipeptide, ramoplanin, in the colonic decontamination of patients colonized with VRE. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (late breaker abstracts) p.16, 26 Sep 1999

    Google Scholar 

  11. Ramoplanin. Clinical Investigator News 7: 21, Aug 1999

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramoplanin. Drugs R&D 3, 271–275 (2002). https://doi.org/10.2165/00126839-200203040-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200203040-00008

Keywords

Search

Navigation